These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 19892663
1. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V. Cancer Prev Res (Phila); 2009 Nov; 2(11):931-41. PubMed ID: 19892663 [Abstract] [Full Text] [Related]
2. Oral cancer prevention advances with a translational trial of green tea. Shin DM. Cancer Prev Res (Phila); 2009 Nov; 2(11):919-21. PubMed ID: 19892661 [Abstract] [Full Text] [Related]
3. Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial. Lu PH, Hsu CH. Complement Ther Med; 2016 Apr; 25():159-63. PubMed ID: 27062963 [Abstract] [Full Text] [Related]
4. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. Clin Cancer Res; 2008 Apr 01; 14(7):2095-101. PubMed ID: 18381950 [Abstract] [Full Text] [Related]
5. Phase I trial of oral green tea extract in adult patients with solid tumors. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS. J Clin Oncol; 2001 Mar 15; 19(6):1830-8. PubMed ID: 11251015 [Abstract] [Full Text] [Related]
9. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Dostal AM, Samavat H, Bedell S, Torkelson C, Wang R, Swenson K, Le C, Wu AH, Ursin G, Yuan JM, Kurzer MS. Food Chem Toxicol; 2015 Sep 15; 83():26-35. PubMed ID: 26051348 [Abstract] [Full Text] [Related]
10. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Altern Med Rev; 2011 Jun 15; 16(2):157-63. PubMed ID: 21649457 [Abstract] [Full Text] [Related]
11. Effects of green tea extract supplementation and endurance training on irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged men. Bagheri R, Rashidlamir A, Ashtary-Larky D, Wong A, Grubbs B, Motevalli MS, Baker JS, Laher I, Zouhal H. Eur J Appl Physiol; 2020 Apr 15; 120(4):915-923. PubMed ID: 32095935 [Abstract] [Full Text] [Related]
12. Phase I study of green tea extract in patients with advanced lung cancer. Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Cancer Chemother Pharmacol; 2005 Jan 15; 55(1):33-8. PubMed ID: 15309507 [Abstract] [Full Text] [Related]
13. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Clin Nutr; 2008 Jun 15; 27(3):363-70. PubMed ID: 18468736 [Abstract] [Full Text] [Related]
15. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Netsch MI, Gutmann H, Luescher S, Brill S, Schmidlin CB, Kreuter MH, Drewe J. Planta Med; 2005 Feb 15; 71(2):135-41. PubMed ID: 15729621 [Abstract] [Full Text] [Related]
16. Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver. Tamura K, Nakae D, Horiguchi K, Akai H, Kobayashi Y, Satoh H, Tsujiuchi T, Denda A, Konishi Y. Jpn J Cancer Res; 1997 Apr 15; 88(4):356-62. PubMed ID: 9197526 [Abstract] [Full Text] [Related]
17. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL. J Hum Nutr Diet; 2015 Jun 15; 28(3):272-82. PubMed ID: 24646362 [Abstract] [Full Text] [Related]
18. Cancer prevention by green tea: evidence from epidemiologic studies. Yuan JM. Am J Clin Nutr; 2013 Dec 15; 98(6 Suppl):1676S-1681S. PubMed ID: 24172305 [Abstract] [Full Text] [Related]
19. Green tea extract supplementation does not modify plasma concentration of F2-isoprostanes in women who are postmenopause: Findings from a randomized controlled trial. Bathgate JR, Radler DR, Kurzer M, Samavat H. Nutr Res; 2023 May 15; 113():29-38. PubMed ID: 37011435 [Abstract] [Full Text] [Related]
20. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells]. Tang XD, Zhou X, Zhang QZ, Le AD, Zhou KY. Zhonghua Yi Xue Za Zhi; 2008 Nov 04; 88(40):2872-7. PubMed ID: 19080502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]